about
Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortalityIncident acute coronary syndromes in chronic dialysis patients in the United StatesUse of beta-blockers and aspirin after myocardial infarction by patient renal function in the Department of Defense health care systemHeart failure as a cause for hospitalization in chronic dialysis patientsRelation between asymptomatic proteinase 3 antibodies and future granulomatosis with polyangiitisImpact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System.Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients--an analysis of USRDS data.Therapeutic plasma exchange as a nephrological procedure: a single-center experience.Thrombotic microangiopathy in United States long-term dialysis patients.An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States.Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review.Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies.The impact of kidney transplantation on heart failure risk varies with candidate body mass index.Trends in renal transplantation in patients with human immunodeficiency virus infection: an analysis of the United States renal data system.Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.Effect of smoking on kidney transplant outcomes: analysis of the United States Renal Data System.Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.Cancer diagnoses after living kidney donation: linking U.S. Registry data and administrative claimsRate of kidney function decline associates with mortalityTreatment of the diabetic patient: focus on cardiovascular and renal risk reduction.Risk of intracranial hemorrhage associated with autosomal dominant polycystic kidney disease in patients with end stage renal disease.Poor outcomes in elderly kidney transplant recipients receiving alemtuzumab induction.What have we learned from the current trials?Asymptomatic autoantibodies associate with future anti-glomerular basement membrane diseaseCardiovascular risk in stage 4 and 5 nephropathy.Outcomes After Post-Traumatic AKI Requiring RRT in United States Military Service Members.Cost-Utility Analysis of Mycophenolate Mofetil versus Azathioprine Based Regimens for Maintenance Therapy of Proliferative Lupus NephritisEpidemiology of dialysis patients and heart failure patients.Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey.Assessment of racial disparities in chronic kidney disease stage 3 and 4 care in the department of defense health system.Novel methods for tracking long-term maintenance immunosuppression regimens.Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failureCardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients.Association of incident gout and mortality in dialysis patientsBody mass index and peritoneal dialysis: "exceptions to the exception" in reverse epidemiology?Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review.Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients.Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study.Derivation of candidates for the combat casualty critical care (C4) database.Impact of Poverty and Health Care Insurance on Arteriovenous Fistula Use among Incident Hemodialysis Patients.
P50
Q24798420-0F5CCE84-B706-4615-86ED-DCE1A64B999DQ28193903-8A487838-5BE4-4C25-9920-A5C15739C49CQ28196073-2287DA06-9AEF-4F2B-BE9B-BE70487399A2Q28196326-A09163CE-DED1-422C-B71F-8880920963CFQ28386741-54B39F1D-2356-4890-8AA2-81D93F52D892Q30745676-BE6A76D2-A829-4BA5-8F02-3B4BFB1855AAQ31095760-BD567DD0-BC3B-42A8-AFE6-6DF766DFA16BQ33367423-F7500F6F-45F4-4288-A106-395518E8674CQ33368800-D4AB89F2-10F1-401A-AE12-4CFE3722A07AQ33427765-448CE31B-B7B9-40B2-BE0C-8E661148286AQ33433368-3C274967-5EF9-42AA-9698-1C07F1FFFE52Q33578171-97EC798B-1900-45AA-A39F-D897812E74ADQ33581566-CEE7E43B-2952-4A66-BA3F-79E5B3018C74Q33814291-24ED50D2-75E0-44C2-8D12-88DBDF2457EDQ33879502-6CCE7C6E-D808-4728-92FE-66F9ED2CEF8CQ34034311-4F9EEE06-321B-4371-949C-C486C2F83C14Q34091229-7EEEB4D5-B44C-4990-BB3F-E332A7D3D6F8Q34349009-13A3BE5A-D6AE-45DA-9DE6-0985EEDBC04BQ34457080-B57AFC3E-1099-4588-A378-6D15EE6035C5Q35000615-99A10820-D35C-40AD-9A79-B676E4B932AFQ35103239-77966C7A-1A6D-4FE4-89E8-3603CDC958BEQ35611179-63055034-89F6-4141-A239-55A9BDA547E7Q35660825-2E53981F-5509-4C85-986A-8D8267502379Q35758321-4ED310AE-C1A7-4D32-8776-D2CA464C505EQ35816560-559BF242-45D0-4B06-BFC6-F5266D09A533Q36123588-774E895D-1C6E-4B3E-A953-00B52F19BBB2Q36265568-D7459851-6591-4BA6-B03F-F7DE9E7348A9Q36418690-F22C5065-18FA-47F6-A1C5-BB82B51BBDB2Q36529492-8259316A-0AEF-4300-A258-225EAC4D17B8Q36666750-1BC0773E-CB79-4062-A6FA-89CFE03A4E6BQ36666963-E20864B8-9DC6-44EC-A353-8286FF9286BEQ36736632-AC59D042-00E9-4BC9-93BF-B44F421A0471Q36736689-1009AB6E-4AE0-466A-924D-17B459964E7FQ36949195-75BA42C0-D533-42C0-A042-A7CB0B363A2EQ36996703-6054E249-9F72-45B2-8CBD-0BD93C0554D6Q37039100-C720AEB7-51D8-438D-AB92-F20FCEA50215Q37860695-9A5C0AF9-48C2-4E44-AC24-D0D564CFEE5FQ38017494-6BF00ED2-EADA-4034-9DD6-53717871CBC9Q38201216-0B87EFD5-DA29-4BC2-9324-7478CE15E46BQ38420517-D35A064E-8CF4-405B-912D-9CA0C1A696B8
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kevin C. Abbott
@ast
Kevin C. Abbott
@en
Kevin C. Abbott
@es
Kevin C. Abbott
@nl
Kevin C. Abbott
@sl
كيفن سي. أبوت
@ar
type
label
Kevin C. Abbott
@ast
Kevin C. Abbott
@en
Kevin C. Abbott
@es
Kevin C. Abbott
@nl
Kevin C. Abbott
@sl
كيفن سي. أبوت
@ar
prefLabel
Kevin C. Abbott
@ast
Kevin C. Abbott
@en
Kevin C. Abbott
@es
Kevin C. Abbott
@nl
Kevin C. Abbott
@sl
كيفن سي. أبوت
@ar
P106
P1153
26643310600
P21
P31
P496
0000-0003-2111-7112